Computerized surveillance of adverse drug reactions in hospital: pilot study

被引:55
作者
Azaz-Livshits, T
Levy, M
Sadan, B
Shalit, M
Geisslinger, G
Brune, K
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Ctr, Div Med, Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Ctr, Div Med Informat, Jerusalem, Israel
[3] Univ Erlangen Nurnberg, Dept Expt & Clin Pharmacol & Toxicol, D-8520 Erlangen, Germany
关键词
hospital pharmacoepidemiology; hospital information systems; adverse drug reactions; drug surveillance;
D O I
10.1046/j.1365-2125.1998.00685.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims To develop and assess the use of computerized laboratory data as a detection support tool of adverse drug reactions (ADRs) in hospital. Methods This was a retrospective observational study of 153 sequential medical admissions during a 2-month period to the 34-bed medical ward at the Hadassah University Hospital, Jerusalem, Israel. Measurements made were 1) Retrospective chart review for recognized and unrecognized adverse drug reactions (ADRs) and 2) Analysis of computerized laboratory data according to defined automatic laboratory signals (ALS) for adverse reactions. Results Forty ADRs have been detected in 38 out of the 153 hospital admissions (24.8%). Nine reactions were considered severe. Altogether 212 ALS were generated involving 86 admissions. In 25 (65.8%) of the ADR-positive admissions ADRs were detected through automatic signals generated from the laboratory data. ALS were detected in 56 out of the 115 (48.7%) ADR-negative admissions. Twenty-four (60%) of the ADRs were not recognized as such by the attending physicians. Two of these reactions were severe. ALS could have generated an alert for 19 (79.2%) of the unrecognized reactions. Conclusions Application of automatic laboratory signals can increase the rate of recognition of ADRs and thereby improve medical care. The sensitivity and specificity of the method might be increased by refinement and redefinition of the signals.
引用
收藏
页码:309 / 314
页数:6
相关论文
共 31 条
[1]  
*ACCR HEALTHC ORG, 1988, JOINT COMM ACCR HEAL
[2]   POTENTIAL IDENTIFIABILITY AND PREVENTABILITY OF ADVERSE EVENTS USING INFORMATION-SYSTEMS [J].
BATES, DW ;
ONEIL, AC ;
BOYLE, D ;
TEICH, J ;
CHERTOW, GM ;
KOMAROFF, AL ;
BRENNAN, TA .
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 1994, 1 (05) :404-411
[3]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[4]   The costs of adverse drug events in hospitalized patients [J].
Bates, DW ;
Spell, N ;
Cullen, DJ ;
Burdick, E ;
Laird, N ;
Petersen, LA ;
Small, SD ;
Sweitzer, BJ ;
Leape, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04) :307-311
[5]   SENSITIVITY AND SPECIFICITY OF 3 METHODS OF DETECTING ADVERSE DRUG-REACTIONS [J].
BERRY, LL ;
SEGAL, R ;
SHERRIN, TP ;
FUDGE, KA .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1988, 45 (07) :1534-1539
[6]   COMPUTER-ASSISTED PHARMACOVIGILANCE IN HOSPITALIZED-PATIENTS [J].
CHAN, TYK .
ANNALS OF PHARMACOTHERAPY, 1995, 29 (7-8) :788-789
[7]   COMPUTERIZED SURVEILLANCE OF ADVERSE DRUG EVENTS IN HOSPITAL PATIENTS [J].
CLASSEN, DC ;
PESTOTNIK, SL ;
EVANS, RS ;
BURKE, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (20) :2847-2851
[8]   Adverse drug events in hospitalized patients - Excess length of stay, extra costs, and attributable mortality [J].
Classen, DC ;
Pestotnik, SL ;
Evans, RS ;
Lloyd, JF ;
Burke, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04) :301-306
[9]  
Classen DC, 1995, INFECT CONT HOSP EP, V16, P729
[10]   ASHP NATIONAL SURVEY OF HOSPITAL-BASED PHARMACEUTICAL SERVICES - 1992 [J].
CRAWFORD, SY ;
MYERS, CE .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (07) :1371-1404